Subscribe and Stay Informed
Receive industry-leading content from our experts
Start exploring
SIV Training Is Still Too Redundant. The Data Shows Where to Start.
In fall 2026, the Advarra-facilitated Site-Sponsor Consortium will release a white paper on reducing redundant site training through competency-based, role-based, and reusable training…
What Is the Difference Between an SAE, AE, and UADE in Clinical Trials?
Adverse events (AEs) are untoward medical occurrences in participants receiving a study intervention, regardless of…
Q&A with Advarra’s Senior Coordinator of Client Services Rachel Garrett
Rachel Garrett’s career in clinical research has come full circle. After starting her journey at…
What Is the Difference Between Monitoring and Auditing in Clinical Trials And Why Do They Matter for Inspection Readiness?
Clinical trial monitoring (CTM) and auditing are both essential quality management activities, but they serve…
Advarra AI Council Members Participate in a Panel at Northwestern University to Discuss the Impacts of AI on Biosecurity
What impact will advancements in artificial intelligence (AI) have on national security and global public…
The Data Monitoring Committee Charter Is Now a Strategic Governance Document
FDA’s 2024 draft guidance signals broader expectations for data monitoring committee (DMC) independence, communication, documentation, and sponsor decision-making. For sponsors…